Investment Firm
Overview
Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.
Apr 12, 2021
Series B
Highlights
Location
Social
Participant Investors
10
Antios Therapeutics raised $96000000 on 2021-04-12 in Series B
Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.
Company Funding History
4
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Nov 27, 2018 | Series A - Antios Therapeutics | 7 | - | 25.0M |
Aug 17, 2020 | Venture Round - Antios Therapeutics | - | 4.4M | |
Apr 12, 2021 | Series B - Antios Therapeutics | 14 | - | 96.0M |
Nov 03, 2021 | Series B - Antios Therapeutics | 20 | - | 75.0M |
Recent Activity
There is no recent news or activity for this profile.